|
1. Scott, B. H., 1988. Pathogenesis of Dengue: Challenges to Molecular Biology, Science 239:476-481. 2. Halstead, S. B., 1980. Immunological parameters of togavirus disease syndromes, p. 107-173. In R. W. Schlesinger (ed.), The togaviruses. Academic Press, Inc., New York. 3. Sabin, A. B., 1959. Dengue, p. 361-373. In T. Rivers and F. Horsfall (ed.), Viral and rickettsial infection of man. J. B. Lippincott Co., Philadelphia. 4. World Health Organization. 1975. Technical guides for diagnosis, treatment, surveillance, prevention and control of dengue hemorrhagic fever. World Health Organization, Geneva. 5. Monath, T. P., 1985. Flaviviruses, p. 955-1004. In B. W. Fields, D. M. Knipa, R. M. Chanock, J. L. Malnick, B. Roizman, and R. E. Shope (ed.), Virology. Raven Press, New York. 6. Sangkawibha, N., Rojanasuphot, S., Ahandrik, S., Viriyapongse, S., Jatanasen, S., Salitul, V., Phanthumachinda, B., Halstead, S. B., 1984. Risk factors in dengue shock syndrome:A prospective epidemiologic study in Rayong, Thailand. Am. J. Epidemiol. 120:653-669 7. Guzman, M. G., Kouri, G. P., Bravo, J., Soler, M., Vazquez, S., Morier, L., 1990. Dengue hemorrhagic fever in Cuba, 1981: A retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42:179-184. 8. Halstead, S. B., 1981. The Alexander D. Langmuir Lewcture. The pathogenesis of dengue: Molecular epidemiology in infectious disease. Am. J. Epidemiol. 114:632-648. 9. Kliks, S. C., Nimmanitya, S., Nisalak, A., Burke, D. S., 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38:411-419. 10.Halstead, S. B., 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp. Med. 146:201-217. 11.Kliks, S. C., Nisalak, A., Brandt, W. E., Wahl, L., Burke, D. S., 1989. Antibody dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J Trop. Med. Hyg. 40:444-451. 12.Morens, D. M., Marchette, N. J., Chu, M. C., Halstead, S. B., 1991. Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. Am. J. Trop. Med. Hyg. 45: 644-651. 13.Rosen, L., 1977. The emperor's new clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 26:337-343. 14.Shaio, M. F., Chang, F. Y., Hou, S. C., 1992. Complement pathoway activity in serum from patients with classical dengue fever. Trans. Roy. Soc. Trop. Med. Hyg. 86:672-675. 15.Shaio, M. F., 1994. Influence of dengue virus infection on the up take and the respiratory burst activity of human monocytes. Immunol. Infect. Dis. 4:69-75. 16.Chang, D. M., Shaio, M. F., 1994. Production of interleukin- 1 (IL-1) and IL-1 inhibitor by human monocytes exposed to dengue virus. J. Infect. Dis. 170:811-817. 17.Shaio, M. F., Cheng. S. N., Yuh, Y. S., Yang. K. D., 1995. Cytotoxic factors released by dengue virus-infected human blood monocytes. J. Med. Virol. 46:216-223. 18.Yang, K. D., Lee, C. S., Hwang, K. P., Chu, M. L., Shaio, M. F., 1995. A model to study cytokine profiles in primary and hetrologously secondary dengue-2 virus infections. Acta. Virol. 39:19-21. 19.Yang, K. D., Lee, C. S., Shaio, M. F., 1995. A higher production of platelet activating factor in ex vivo heterologously secondary dengue-2 virus infections. Acta. Micro. Immunol. Hungarica. 42:403-407. 20.Yang, K. D., Wang, C. L., Shaio, M. F., 1995. Production of cytokines and platelet activating factor in secondary dengue virus infection. J. Infect. Dis. 172:604-605. 21.Kurane, I., B. L. Innis, A. Nisalak, C. Hoke, S. Nimmanitya, A. Meager, and F. A. Ennis. 1989. Human responses to dengue virus antigens. Proliferative responses and interferon gamma production. J. Clin. Invest. 83:506-513. 22.Bukowski, J. F, I. Kurane, C. J. Lai, M. Bray, B. Falgout, and F. A. Ennis. 1989. Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J. Virol. 63:5086-5091. 23.Kurane, I., A. Meager, and F. A. Ennis. 1989. Dengue virus- specific human T cell clones. Serotype cross-reactive proliferation, interferon gamma production, and cytotoxic activity. J. Exp. Med. 170:763-775. 24.Konty, U., I. Kurane, and F. A. Ennis. 1988. Gamma interferon of human monocytic cells. J. Virol. 62:3928-3933. 25.Bukowski, J. F., Kurane, I., Lai, C. J., Bray, M., Falgout, B., Ennis, F. A., 1989. Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J. Virol. 12:5086-91. 26.Schlesinger, R. W. 1977. Dengue viruses. Springer-Verlag, New York. 27.Despres, P., Flamand, M., Ceccaldi, P. E., Deubel, V., 1996. Human isolates of dengue type 1 virus induce apoptosis in mouse neuroblastoma cells. J. Virol. 70:4090-4096. 28.Marianneau, P., Cardona, A., Edelman, L., Deubel, V., Despres, P., 1997. Dengue virus replication in human hepatoma cells activates NF-B which in turn induces apoptotic cell death. J. Virol. 71:3244-3249. 29.Despres, P., Frenkiel, M. P., Ceccaldi, P. E., Duarte, Dos., Santos, C., Deubel, V., 1998. Apoptosis in the mouse central nervous system in response to infection with mouse- neurovirulent dengue viruses. J. Virol. 72:823-829. 30.Monath, T. P., 1985. Flaviviruses. In:Fields BN, et al. (eds) Virology. Raven Press, New York, p 955. 31.Halstead, S. B., O'Rourke, E. J., Allison, A. C., 1977. Dengue virus and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J. Exp. Med. 146:218-229. 32.Kurane, I., Kontny, U., Janus, J., Ennis, F. A., 1990. Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch. Viro. 110:91- 101. 33.Halstead S. B., 1979. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infec. Dis. 140:527-33. 34.Marchette, N. J., Halstead, S. B., Chow, J. S., 1976. Replication of dengue viruses in cultures of peripheral blood leukocytes from dengue-immune rhesus monkeys. J. Infec. Dis. 133:274-282. 35.Marchette, N. J., 1974. Immunopathogenesis of dengue infection in the rhesus monkey. Transplant. Proce. 6:197-201. 36.La Russa, V. F., Innis, B. L., 1995. Mechanisms of dengue virus-induced bone marrow suppression. Bailli. Clin. Haema. 8:249-270. 37.Murgue, B., Cassar, O., Guigon, M., Chungue, E., 1997. Dengue virus inhibits human hematopoietic progenitor growth in vitro. Journal of Infectious Diseases. 175:1497-1501. 38.Rothwell, S. W., Putnak, R., La Russa, V.F., 1996. Dengue-2 virus infection of human bone marrow: characterization of dengue-2 antigen-positive stromal cells. Am. J. Trop. Med. Hyg. 54:503-510. 39.Collins, K. L., Mary, and Abelardo Lopez Rivas, 1993. The control of apoptosis in mammalian cells. TIBS 18:307-309. 40.Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., Henson, P. M., 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immuno. 148:2207-2216. 41.Mower, D. A. Jr., Peckham, D. W., Illera,V. A., Fishbaugh, J. K., Stunz, L. L., Ashman, R. F., 1994. Decreased membrane phospholipid packing and decreased cell size proceed DNA cleavage in mature mouse B cell apoptosis. J. Immuno. 152:4832-4842. 42.Duke, R. C., Cohen, J. J., 1986. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lympho. Resear. 5:289-99. 43.Siebenlist, U., Franzoso, G., Brown, K., 1994. Structure, regulation and function of NF-B. Annu. Rev. Cell Biol. 10:405-455. 44.Thanos, D., Maniatis, T., 1995. NF-B:a lesson in family values. Cell 80:529-532. 45.Lin, K. I., Lee, S. H., Narayanan, R., Baraban, J. M., Hardwick, J. M., Ratan, R. R., 1995. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-B. J. Cell Biol. 131:1149-1161. 46.Cleveland, L., John, and James, N., Ihle, 1995. Contenders in FasL/TNF death signaling. Cell 81: 479-182. 47.Halstead, S. B., 1990. Global epidemiology of dengue hemorrhagic fever. Southeast Asia J. Trop. Med. Public. Health. 21:636. 48.Morens, D. M., Halstead, S. B., Repik, P. M., Putvatana, R., Raybourne, N., 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22:250-254 49.Sambrook, J., 1989. Molecular cloning. 50.Liu, H. S., Tzeng, H. C., Chang, T. Y., Chen, C. C., 1994. Using a radioactive and non-radioactive exchangeable labeling system for laboratory diagnosis. Kaohsiung. J. Med. Sci. 10:165-169. 51.Wengler, G., Wengler, G., Gross, H. J., 1978. Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with Flavivirus. Virology 89:423-437. 52.Guirakhoo, F., A. R. Hunt, J. G. Lewis, and J. T. Roehring. 1993. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 194:219-223 53.Kawano, H., V. Rostapshov, and C-J. Lai. 1993. Genetic determinents of dengue type 4 virus neurovirulence to mice. J. Virol. 67:6567-6575. 54.O'Sullivan, M. A., Killen, H. M., 1994. The differentiation state of monocytic cells affects their susceptibility infection and the effects of infection by dengue virus. 75:2387-2392. 55.Tsujimoto, Y., Croce, C. M., 1986. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. 83:5214-5218. 56.Ivanov VN. Lee RK. Podack ER. Malek TR. 1997. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF- kappa B. Oncogene. 14:2455-2464.
|